156 HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: MAINTENANCE THERAPY WITH PEGYLATED INTERFERON IN NONRESPONDERS TO STANDARD THERAPY SLOWS THE DISEASE PROGRESSION AND IMPROVES SURVIVAL.

MLA

Crespo, G., et al. “156 Hepatitis C Recurrence After Liver Transplantation: Maintenance Therapy with Pegylated Interferon in Nonresponders to Standard Therapy Slows the Disease Progression and Improves Survival.” Journal of Hepatology, vol. 58, Apr. 2013, p. S70. EBSCOhost, https://doi.org/10.1016/S0168-8278(13)60158-0.

APA

Crespo, G., Garc, I., Mari, Z., Londo, M.-C., Lens, S., Carri, J. A., Navasa, M., & Forns, X. (2013). 156 Hepatitis C Recurrence After Liver Transplantation: Maintenance Therapy with Pegylated Interferon in Nonresponders to Standard Therapy Slows the Disease Progression and Improves Survival. Journal of Hepatology, 58, S70. https://doi.org/10.1016/S0168-8278(13)60158-0

Chicago

Crespo, G., I. Garc, Z. Mari, M.-C. Londo, S. Lens, J.A. Carri, M. Navasa, and X. Forns. 2013. “156 Hepatitis C Recurrence After Liver Transplantation: Maintenance Therapy with Pegylated Interferon in Nonresponders to Standard Therapy Slows the Disease Progression and Improves Survival.” Journal of Hepatology 58 (April): S70. doi:10.1016/S0168-8278(13)60158-0.